|
WO2005042060A2
|
|
Method and composition comprising pyruvate, inosine, adenine, phosphate and an aziridino compound for treating a biological sample
|
|
US2004137419A1
|
|
Methods for removing microbicidal compounds from compositions
|
|
US2004048235A1
|
|
Methods and compositions for the selective modification of nucleic acids
|
|
US2004053208A1
|
|
Methods to selectively inactivate parasites in biological compositions
|
|
WO03093512A1
|
|
Methods and compositions for the modification of nucleic acids
|
|
CA2466251A1
|
|
Therapeutic use of aziridino compounds
|
|
AU2002320059A1
|
|
Method of assessing levels of infectious virus in a biological sample
|
|
WO02092806A1
|
|
Apparatus for the inactivation of pathogens in protein-containingfluids
|
|
WO02067956A2
|
|
Method for purifying a biological composition
|
|
WO02055095A2
|
|
Use of aziridino-compounds in the treatment of immune dysfunctions
|
|
IL152116D0
|
|
Prion-binding ligands and methods of using same
|
|
WO0140265A2
|
|
Ligands for a target molecule and a method for indentifying them
|
|
CA2385179A1
|
|
Isoagglutinin-depleted blood compositions and methods of making same
|
|
AU6361100A
|
|
Nucleic acids for detecting parvovirus and methods of using same
|
|
US6642033B1
|
|
Nucleic acids for detecting parvovirus and methods of using same
|
|
WO0104599A1
|
|
Coring device
|
|
US6215003B1
|
|
Synthesis of ethyleneimine dimer
|
|
US6617100B2
|
|
Solid phase quenching systems
|
|
US6150109A
|
|
Lipophilic quenching of viral inactivating agents
|
|
US6403359B1
|
|
Solid phase quenching systems
|
